Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas M MacDonald

Showing results (151-160 of 159) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 159 results.
Journal of Clinical Medicine|October 13, 2021
Secondary Stroke Prevention in Polish Adults: Results from the LIPIDOGRAM2015 StudyBeata Labuz-Roszak, Maciej Banach, Michal Skrzypek, et al.
European Journal of Preventive Cardiology|April 11, 2023
Metabolic syndrome is associated with similar long-term prognosis in those living with and without obesity: an analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004-2015 studiesKamila Osadnik, Tadeusz Osadnik, Marek Gierlotka, et al.
Journal of Clinical Medicine|December 10, 2021
The Differences in the Prevalence of Cardiovascular Disease, Its Risk Factors, and Achievement of Therapeutic Goals among Urban and Rural Primary Care Patients in Poland: Results from the LIPIDOGRAM 2015 StudyKrzysztof Studziński, Tomasz Tomasik, Adam Windak, et al.
European Heart Journal|October 6, 2016
Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT)Thomas M MacDonald, Chris J Hawkey, Ian Ford, et al.
Archives of Medical Science : AMS|May 20, 2022
Design and rationale of a nationwide screening analysis from the LIPIDOGRAM2015 and LIPIDOGEN2015 studiesJacek J Jóźwiak, Sławomir Kasperczyk, Tomasz Tomasik, et al.
Diabetologia|December 8, 2014
Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysisDaniel Levin, Samira Bell, Reijo Sund, et al.
The Lancet. Primary Care|June 18, 2026
Chemical adherence testing-guided intervention versus standard of care in patients with hypertension who are non-adherent to antihypertensive treatment in the UK (OUTREACH): a multicentre, randomised controlled trialMaciej Tomaszewski, Pankaj Gupta, Philip Chowienczyk, et al.
Nature Genetics|November 5, 2024
Publisher Correction: A genome-wide association analysis reveals new pathogenic pathways in goutTanya J Major, Riku Takei, Hirotaka Matsuo, et al.
Nature Genetics|October 15, 2024
A genome-wide association analysis reveals new pathogenic pathways in goutTanya J Major, Riku Takei, Hirotaka Matsuo, et al.
Pageof 16

Showing results (151-160 of 159) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 159 results.
Journal of Clinical Medicine|October 13, 2021
Secondary Stroke Prevention in Polish Adults: Results from the LIPIDOGRAM2015 StudyBeata Labuz-Roszak, Maciej Banach, Michal Skrzypek, et al.
European Journal of Preventive Cardiology|April 11, 2023
Metabolic syndrome is associated with similar long-term prognosis in those living with and without obesity: an analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004-2015 studiesKamila Osadnik, Tadeusz Osadnik, Marek Gierlotka, et al.
Journal of Clinical Medicine|December 10, 2021
The Differences in the Prevalence of Cardiovascular Disease, Its Risk Factors, and Achievement of Therapeutic Goals among Urban and Rural Primary Care Patients in Poland: Results from the LIPIDOGRAM 2015 StudyKrzysztof Studziński, Tomasz Tomasik, Adam Windak, et al.
European Heart Journal|October 6, 2016
Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT)Thomas M MacDonald, Chris J Hawkey, Ian Ford, et al.
Archives of Medical Science : AMS|May 20, 2022
Design and rationale of a nationwide screening analysis from the LIPIDOGRAM2015 and LIPIDOGEN2015 studiesJacek J Jóźwiak, Sławomir Kasperczyk, Tomasz Tomasik, et al.
Diabetologia|December 8, 2014
Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysisDaniel Levin, Samira Bell, Reijo Sund, et al.
The Lancet. Primary Care|June 18, 2026
Chemical adherence testing-guided intervention versus standard of care in patients with hypertension who are non-adherent to antihypertensive treatment in the UK (OUTREACH): a multicentre, randomised controlled trialMaciej Tomaszewski, Pankaj Gupta, Philip Chowienczyk, et al.
Nature Genetics|November 5, 2024
Publisher Correction: A genome-wide association analysis reveals new pathogenic pathways in goutTanya J Major, Riku Takei, Hirotaka Matsuo, et al.
Nature Genetics|October 15, 2024
A genome-wide association analysis reveals new pathogenic pathways in goutTanya J Major, Riku Takei, Hirotaka Matsuo, et al.
Pageof 16